NHT-0112

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNHT-0112
Drug Alias Nameanti-amyloid compound (Neuro-Hitech)NHT-0112
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitorsMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tauBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeuro-Hitech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuro-Hitech
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A